Regulation of MT1-MMP Activity by β-catenin in MDCK Non-cancer and HT1080 Cancer Cells

Overview

Journal J Cell Physiol

Specialties Cell Biology
Physiology

Date 2010 Jul 1

PMID 20589835

Citations 12

Authors

Ping Liu

Jianbo Yang

Jing Pei

Duanqing Pei

Michael J Wilson

Affiliations

Soon will be listed here.

Abstract

Past studies on β-catenin in cancer cells focused on nuclear localized β-catenin and its involvement in the Wnt pathway. Our goal here was to investigate the function of β-catenin in both the cytoplasm and nucleus on the regulation of MT1-MMP expression and activity. We found that β-catenin in MDCK non-cancer cells inhibited the cell surface localization of MT1-MMP, and thus its proteolytic activity on pro-MMP2 activation, via direct interaction with the 18-amino-acid cytoplasmic tail of MT1-MMP in the cytoplasm. In contrast, β-catenin in HT1080 cancer cells enhanced the activity of MT1-MMP by entering the nucleus and activating transcription factor Tcf-4/Lef, and elevating the level of MT1-MMP protein. We also found that enhancement of cell growth in three-dimensional (3-D)/two-dimensional (2-D) type I collagen gels and of cell migration by MT1-MMP were inhibited by β-catenin in MDCK cells, whereas these functions were enhanced in HT1080 cells. In addition, regulation of MT1-MMP by β-catenin involved E-cadherin in MDCK cells and Wnt-3a in HT1080 cells. Taken together, our results present a differential effect of cytoplasmic and nuclear β-catenin on MT1-MMP activity in non-cancer cells versus cancer cells. These differences were most probably due to different subcellular locations and different involved pathways of β-catenin in these cells.

Citing Articles

Nodular and Micronodular Basal Cell Carcinoma Subtypes Are Different Tumors Based on Their Morphological Architecture and Their Interaction with the Surrounding Stroma.

Serbanescu M, Bungardean R, Georgiu C, Crisan M Diagnostics (Basel). 2022; 12(7).

PMID: 35885545 PMC: 9323345. DOI: 10.3390/diagnostics12071636.

Rapalog resistance is associated with mesenchymal-type changes in Tsc2-null cells.

Valianou M, Filippidou N, Johnson D, Vogel P, Zhang E, Liu X Sci Rep. 2019; 9(1):3015.

PMID: 30816188 PMC: 6395747. DOI: 10.1038/s41598-019-39418-5.

Directed Evolution to Engineer Monobody for FRET Biosensor Assembly and Imaging at Live-Cell Surface.

Limsakul P, Peng Q, Wu Y, Allen M, Liang J, Remacle A Cell Chem Biol. 2018; 25(4):370-379.e4.

PMID: 29396288 PMC: 5910193. DOI: 10.1016/j.chembiol.2018.01.002.

Aldose reductase modulates acute activation of mesenchymal markers via the β-catenin pathway during cardiac ischemia-reperfusion.

Thiagarajan D, O Shea K, Sreejit G, Ananthakrishnan R, Quadri N, Li Q PLoS One. 2017; 12(11):e0188981.

PMID: 29190815 PMC: 5708684. DOI: 10.1371/journal.pone.0188981.

MT1-MMP Inhibits the Activity of Bst-2 via Their Cytoplasmic Domains Dependent Interaction.

Fan L, Liu L, Zhu C, Zhu Q, Lu S, Liu P Int J Mol Sci. 2016; 17(6).

PMID: 27240342 PMC: 4926352. DOI: 10.3390/ijms17060818.

References

Sounni N, Rozanov D, Remacle A, Golubkov V, Noel A, Strongin A . Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells. Int J Cancer. 2009; 126(5):1067-78. PMC: 2864114. DOI: 10.1002/ijc.24690. View

Takemaru K, Ohmitsu M, Li F . An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics. Handb Exp Pharmacol. 2008; (186):261-84. DOI: 10.1007/978-3-540-72843-6_11. View

Barth A, Nathke I, Nelson W . Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol. 1997; 9(5):683-90. DOI: 10.1016/s0955-0674(97)80122-6. View

Mercure M, Ginnan R, Singer H . CaM kinase II delta2-dependent regulation of vascular smooth muscle cell polarization and migration. Am J Physiol Cell Physiol. 2008; 294(6):C1465-75. PMC: 3689296. DOI: 10.1152/ajpcell.90638.2007. View

Lehti K, Lohi J, Juntunen M, Pei D, Keski-Oja J . Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J Biol Chem. 2002; 277(10):8440-8. DOI: 10.1074/jbc.M109128200. View

Covington M, Burghardt R, Parrish A . Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am J Physiol Renal Physiol. 2005; 290(1):F43-51. DOI: 10.1152/ajprenal.00179.2005. View

Uekita T, Itoh Y, Yana I, Ohno H, Seiki M . Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol. 2002; 155(7):1345-56. PMC: 2199326. DOI: 10.1083/jcb.200108112. View

Hlubek F, Spaderna S, Jung A, Kirchner T, Brabletz T . Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas. Int J Cancer. 2003; 108(2):321-6. DOI: 10.1002/ijc.11522. View

Kang T, Yi J, Yang W, Wang X, Jiang A, Pei D . Functional characterization of MT3-MMP in transfected MDCK cells: progelatinase A activation and tubulogenesis in 3-D collagen lattice. FASEB J. 2000; 14(15):2559-68. DOI: 10.1096/fj.00-0269com. View

10.

Galvez B, Matias-Roman S, Yanez-Mo M, Vicente-Manzanares M, Sanchez-Madrid F, Arroyo A . Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol Biol Cell. 2003; 15(2):678-87. PMC: 329288. DOI: 10.1091/mbc.e03-07-0516. View

11.

Seiki M . The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol. 2002; 14(5):624-32. DOI: 10.1016/s0955-0674(02)00363-0. View

12.

Nawrocki-Raby B, Gilles C, Polette M, Martinella-Catusse C, Bonnet N, Puchelle E . E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. Am J Pathol. 2003; 163(2):653-61. PMC: 1868220. DOI: 10.1016/S0002-9440(10)63692-9. View

13.

Seiki M . Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 2003; 194(1):1-11. DOI: 10.1016/s0304-3835(02)00699-7. View

14.

Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y . Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 1997; 272(4):2446-51. DOI: 10.1074/jbc.272.4.2446. View

15.

Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V . Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol. 2000; 148(3):615-24. PMC: 2174802. DOI: 10.1083/jcb.148.3.615. View

16.

Bachis A, Mallei A, Cruz M, Wellstein A, Mocchetti I . Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. Neuropharmacology. 2008; 55(7):1114-20. PMC: 2590765. DOI: 10.1016/j.neuropharm.2008.07.014. View

17.

Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N . Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J. 2001; 20(17):4782-93. PMC: 125610. DOI: 10.1093/emboj/20.17.4782. View

18.

Brown P, Levy A, Margulies I, Liotta L, Stetler-Stevenson W . Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 1990; 50(19):6184-91. View

19.

Novak A, Dedhar S . Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci. 2001; 56(5-6):523-37. PMC: 11146752. DOI: 10.1007/s000180050449. View

20.

Bravo-Cordero J, Marrero-Diaz R, Megias D, Genis L, Garcia-Grande A, Garcia M . MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. EMBO J. 2007; 26(6):1499-510. PMC: 1829373. DOI: 10.1038/sj.emboj.7601606. View